CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Operating expenses:
Research and development	$ 1,606,100	$ 1,656,100	$ 2,431,800	$ 2,028,700
General and administrative	1,493,600	3,730,500	2,631,200	5,179,000
Total operating expenses	3,099,700	5,386,600	5,063,000	7,207,700
Loss from operations	(3,099,700)	(5,386,600)	(5,063,000)	(7,207,700)
Other expenses, net:
Interest expense, net	(1,400)	(12,200)	(2,800)	(767,300)
Change in warrant liability	0	0	0	(1,894,700)
Loss on extinguishment of debt	0	(1,649,300)	0	(26,700,200)
Loss before income taxes	(3,101,100)	(7,048,100)	(5,065,800)	(36,569,900)
Income taxes	0	0	(2,400)	(2,300)
Net loss	(3,101,100)	(7,048,100)	(5,068,200)	(36,572,200)
Accrued dividends on Series B Preferred stock	(241,000)	(614,700)	(780,800)	(828,000)
Deemed dividend on Series B Preferred Units	0	(886,900)	(111,100)	(1,143,100)
Net loss attributable to common stockholders	$ (3,342,100)	$ (8,549,700)	$ (5,960,100)	$ (38,543,300)
Basic and diluted net loss attributable to common stockholders per common share	$ (0.42)	$ (5.26)	$ (0.91)	$ (24.21)
Weighted average shares used in computing basic and diluted net loss attributable to common stockholders per common share	8,041,619	1,624,371	6,577,769	1,592,104
Comprehensive loss	$ (3,101,100)	$ (7,048,100)	$ (5,068,200)	$ (36,572,200)